Year: 2021

Oakland, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) — Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that the holders of the Company’s units may elect to separately trade the Class A common shares and warrants underlying the units commencing on November 26, 2021. Those units not separated will continue to trade on the NASDAQ Capital Market under the symbol “PBAXU” and the Class A common shares and warrants are expected to trade under the symbols “PBAX” and “PBAXW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, Nov. 22, 2021 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has closed a non-brokered private placement for aggregate gross proceeds of C$5,992,940.70 (the “Offering”). The Offering consisted of the issuance of 6,658,823 flow-through common shares of the Corporation (the “FT Shares”) at a price of C$0.90 per FT Share. The gross proceeds from the sale of the FT Shares will be used by the Corporation to incur eligible “Canadian exploration expenses” that qualify as “flow-through mining expenditures” within the meaning of subsection 66(15) of the Income Tax Act (Canada) and section 359.1 of the Taxation Act (Québec) related...

SUNNYVALE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of Class A common stock of 23andMe that were issued under the Warrant Agreement, dated October 1, 2020 (the “Warrant Agreement”), by and between 23andMe and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agent”), as part of the units sold in the initial public offering (the “IPO”) of 23andMe, which was formerly known as VG Acquisition Corp., and that remain outstanding at 5:00 p.m. New York City time on December 22, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition, 23andMe will redeem all of its outstanding...

SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) announced today that it has agreed to acquire four modern Aframax LR2 product tankers for an aggregate purchase price of $160 million in combination with long term time charters to a subsidiary of Trafigura, a world-leading commodity trading and logistics company. The vessels are built in 2014 and 2015 and have modern eco-design features including exhaust gas cleaning systems. The Company expects to take delivery of the vessels between December 2021 and February 2022. The sellers are affiliates of Frontline Limited (“Frontline”) and the purchase price is in line with valuations by independent shipbrokers. Hemen Holdings Ltd., who owns approximately 20% of the Company’s issued and outstanding shares, is also a major shareholder in Frontline. The charter period of the vessels will...

SCOTTSDALE, Ariz., Nov. 22, 2021 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will participate in a fireside chat at the upcoming Evercore ISI 4th Annual HealthCONx Conference, which is being hosted virtually. Details of the fireside chat are as follows:Presenters: Michael Lester, CEO, and J. Michael Bruff, CFODate: Thursday, December 2, 2021 Time: 1:50 p.m. (Eastern time)Moderated by: Elizabeth Anderson The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website (https://investor.lifestance.com).   A replay of the webcast will be available after the conclusion of the event and can be accessed on the LifeStance Health...

Mechelen, Belgium; 22 November 2021, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces completion of recruitment in the MANGROVE Phase 2 trial with investigational CFTR inhibitor GLPG2737 in patients with autosomal dominant polycystic kidney disease (ADPKD). MANGROVE is a randomized, double-blind, placebo-controlled trial evaluating a once-daily oral dose of GLPG2737 (NCT04578548). The drug candidate or placebo is administered for 52 weeks, followed by an open-label extension period of 52 weeks, in 66 ADPKD patients with rapidly progressing disease. Patients are randomized in a 2:1 ratio of treatment to placebo. Primary objectives of the trial are to assess the effect on growth of total kidney volume over 52 weeks compared to placebo as well as overall safety and tolerability. Secondary objectives include renal function,...

SAN JOSE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, since the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Form 10-Q”), the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) for continued listing. Under the Nasdaq Listing Rules, the Company has 60 calendar days to submit a plan to regain compliance (the “Plan”) and, if Nasdaq accepts the Plan, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q original filing due date, or until May 16, 2022, to regain compliance. The Company intends...

KENNETT SQUARE, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) — Genesis HealthCare today announced that 28 of its affiliated skilled nursing facilities were identified as Best Nursing Homes for 2021-22 by U.S. News & World Report (U.S. News). Only 13% of the nation’s skilled nursing facilities earned the U.S. News High Performing rating. U.S. News offers comprehensive information about care, safety, health inspections, staffing and more for almost all nursing homes in the country.  Individuals can easily conduct a customized search for a highly rated nursing home by location, Medicare and Medicaid coverage, Alzheimer’s care and size. U.S. News relies on data from Nursing Home Compare, a program run by the Centers for Medicare & Medicaid Services (CMS), the federal agency that sets and enforces standards for nursing...